BG43188A3 - Method for preparing of n- heterocyclyl- 4- piperidine amines - Google Patents
Method for preparing of n- heterocyclyl- 4- piperidine aminesInfo
- Publication number
- BG43188A3 BG43188A3 BG067673A BG6767384A BG43188A3 BG 43188 A3 BG43188 A3 BG 43188A3 BG 067673 A BG067673 A BG 067673A BG 6767384 A BG6767384 A BG 6767384A BG 43188 A3 BG43188 A3 BG 43188A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- heterocyclyl
- piperidinamines
- preparing
- piperidine
- residue
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940082988 antihypertensives serotonin antagonists Drugs 0.000 abstract 1
- 239000003420 antiserotonin agent Substances 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55674283A | 1983-11-30 | 1983-11-30 | |
| US06/660,608 US4695569A (en) | 1983-11-30 | 1984-10-12 | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG43188A3 true BG43188A3 (en) | 1988-04-15 |
Family
ID=27071241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG067673A BG43188A3 (en) | 1983-11-30 | 1984-11-26 | Method for preparing of n- heterocyclyl- 4- piperidine amines |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0144101B1 (fr) |
| JP (1) | JPH0692389B2 (fr) |
| AU (1) | AU579121B2 (fr) |
| BG (1) | BG43188A3 (fr) |
| CA (1) | CA1257258A (fr) |
| CZ (1) | CZ281114B6 (fr) |
| DE (1) | DE3484096D1 (fr) |
| DK (1) | DK567884A (fr) |
| FI (1) | FI80446C (fr) |
| GR (1) | GR81097B (fr) |
| HU (1) | HU199837B (fr) |
| IL (1) | IL73686A (fr) |
| MA (1) | MA20281A1 (fr) |
| NO (1) | NO164171C (fr) |
| NZ (1) | NZ210339A (fr) |
| PH (2) | PH23692A (fr) |
| PT (1) | PT79562B (fr) |
| RO (1) | RO90414A (fr) |
| SK (1) | SK278443B6 (fr) |
| ZW (1) | ZW19484A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634704A (en) * | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
| US4588722A (en) * | 1984-01-09 | 1986-05-13 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| CA1260474A (fr) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Derives de benzoxazol- et de benzothiazolamine |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
| FR2587029B1 (fr) * | 1985-09-11 | 1987-10-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| CA1327579C (fr) * | 1986-02-03 | 1994-03-08 | Frans Eduard Janssens | Compositions antihistaminiques renfermant des n-heterocyclylpiperidin-4-amines |
| NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
| GB8900380D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
| CA2043564A1 (fr) * | 1990-07-06 | 1992-01-07 | Alfons G. M. De Knaep | 3-[(5-methyl-2-furyl)methyl]-n-(4-piperidyl)-3h-imidazo[4,5-b]pyridin-2-amine 2-hydroxypropane-1,2,3-tricarboxylate |
| DK0920865T3 (da) * | 1992-09-03 | 2004-04-19 | Sepracor Inc | Farmaceutiske sammensætninger indeholdende norastemizol |
| CN1052224C (zh) * | 1993-04-07 | 2000-05-10 | 大塚制药株式会社 | 哌啶衍生物、含有它的外周血管舒张剂及其应用 |
| FR2731707B1 (fr) * | 1995-03-13 | 1997-04-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| IL132575A0 (en) * | 1997-05-01 | 2001-03-19 | Nissan Chemical Ind Ltd | Benzimidazole derivative |
| EP1400519B1 (fr) * | 1999-06-28 | 2007-03-07 | Janssen Pharmaceutica N.V. | Inhibiteur du virus respiratoire syncytial |
| EP1418175A1 (fr) | 1999-06-28 | 2004-05-12 | Janssen Pharmaceutica N.V. | Inhibiteurs de réplication du virus respiratoire syncytial |
| ATE258928T1 (de) | 1999-06-28 | 2004-02-15 | Janssen Pharmaceutica Nv | Respiratorisches syncytialvirus replikation inhibitoren |
| JO2352B1 (en) * | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Compounds for the treatment of non-adaptation of the bottom of the uterus |
| JP4155351B2 (ja) * | 2001-02-20 | 2008-09-24 | 中外製薬株式会社 | 代謝調節剤として有用なマロニル−CoA脱炭酸酵素阻害剤としてのアゾール |
| US7709510B2 (en) | 2001-02-20 | 2010-05-04 | Chugai Seiyaku Kabushiki Kaisha | Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| JP4727579B2 (ja) | 2003-08-01 | 2011-07-20 | 中外製薬株式会社 | マロニル−CoAデカルボキシラーゼ阻害剤として有用なシアノアミド化合物 |
| EP2208495B1 (fr) | 2003-08-01 | 2011-12-14 | Chugai Seiyaku Kabushiki Kaisha | Composes azole a base de cyanoguanidine-utilises comme inhibiteurs de malonyl-coa decarboxylase |
| EP1653957B1 (fr) | 2003-08-01 | 2008-07-09 | Chugai Seiyaku Kabushiki Kaisha | Composes de piperidine utiles en tant qu'inhibiteurs de malonyl-coa decarboxylase |
| DE602004030017D1 (de) | 2003-08-01 | 2010-12-23 | Chugai Pharmaceutical Co Ltd | Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer |
| MY142362A (en) | 2004-01-29 | 2010-11-30 | Otsuka Pharma Co Ltd | Pharmaceutical composition for promoting angiogenesis |
| ATE460402T1 (de) * | 2004-05-12 | 2010-03-15 | Bristol Myers Squibb Co | Für die behandlung von thrombotischen leiden geeignete harnstoffantagonisten des p2y1- rezeptors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1140119A (fr) * | 1978-04-03 | 1983-01-25 | Joseph Torremans | Nouvelles n-heterocycle-4-piperidinamines |
| US4219559A (en) * | 1979-01-10 | 1980-08-26 | Janssen Pharmaceutica N.V. | N-Heterocyclyl-4-piperidinamines |
| US4556660A (en) * | 1982-07-12 | 1985-12-03 | Janssen Pharmaceutica N.V. | N-(Bicyclic heterocyclyl)-4-piperidinamines |
| US4634704A (en) * | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| US4588722A (en) * | 1984-01-09 | 1986-05-13 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
-
1984
- 1984-11-07 EP EP84201611A patent/EP0144101B1/fr not_active Expired - Lifetime
- 1984-11-07 DE DE8484201611T patent/DE3484096D1/de not_active Expired - Fee Related
- 1984-11-23 PH PH31479A patent/PH23692A/en unknown
- 1984-11-26 CA CA000468587A patent/CA1257258A/fr not_active Expired
- 1984-11-26 NZ NZ210339A patent/NZ210339A/en unknown
- 1984-11-26 BG BG067673A patent/BG43188A3/xx unknown
- 1984-11-28 CZ CS849128A patent/CZ281114B6/cs unknown
- 1984-11-28 MA MA20505A patent/MA20281A1/fr unknown
- 1984-11-28 PT PT79562A patent/PT79562B/pt not_active IP Right Cessation
- 1984-11-28 SK SK9128-84A patent/SK278443B6/sk unknown
- 1984-11-29 JP JP59250660A patent/JPH0692389B2/ja not_active Expired - Lifetime
- 1984-11-29 DK DK567884A patent/DK567884A/da not_active Application Discontinuation
- 1984-11-29 FI FI844708A patent/FI80446C/fi not_active IP Right Cessation
- 1984-11-29 NO NO844755A patent/NO164171C/no unknown
- 1984-11-29 GR GR81097A patent/GR81097B/el unknown
- 1984-11-29 AU AU36028/84A patent/AU579121B2/en not_active Ceased
- 1984-11-29 ZW ZW194/84A patent/ZW19484A1/xx unknown
- 1984-11-29 IL IL73686A patent/IL73686A/xx unknown
- 1984-11-30 RO RO84116474A patent/RO90414A/fr unknown
- 1984-11-30 HU HU844444A patent/HU199837B/hu not_active IP Right Cessation
-
1991
- 1991-01-18 PH PH41871A patent/PH30787A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK567884D0 (da) | 1984-11-29 |
| CA1257258A (fr) | 1989-07-11 |
| NO844755L (no) | 1985-05-31 |
| MA20281A1 (fr) | 1985-07-01 |
| PT79562A (en) | 1984-12-01 |
| EP0144101B1 (fr) | 1991-02-06 |
| EP0144101A3 (en) | 1985-07-24 |
| EP0144101A2 (fr) | 1985-06-12 |
| FI80446B (fi) | 1990-02-28 |
| DE3484096D1 (de) | 1991-03-14 |
| AU3602884A (en) | 1985-06-06 |
| CZ281114B6 (cs) | 1996-06-12 |
| ZW19484A1 (en) | 1986-05-07 |
| FI844708A0 (fi) | 1984-11-29 |
| PH30787A (en) | 1997-10-17 |
| GR81097B (en) | 1985-04-04 |
| HU199837B (en) | 1990-03-28 |
| NO164171C (no) | 1990-09-05 |
| RO90414A (fr) | 1986-12-10 |
| HUT35677A (en) | 1985-07-29 |
| NZ210339A (en) | 1987-05-29 |
| SK912884A3 (en) | 1997-05-07 |
| FI80446C (fi) | 1990-06-11 |
| IL73686A0 (en) | 1985-02-28 |
| JPH0692389B2 (ja) | 1994-11-16 |
| DK567884A (da) | 1985-05-31 |
| NO164171B (no) | 1990-05-28 |
| IL73686A (en) | 1988-05-31 |
| AU579121B2 (en) | 1988-11-17 |
| FI844708L (fi) | 1985-05-31 |
| SK278443B6 (en) | 1997-05-07 |
| JPS60149583A (ja) | 1985-08-07 |
| CZ912884A3 (en) | 1996-01-17 |
| PT79562B (en) | 1986-12-15 |
| PH23692A (en) | 1989-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG43007A3 (en) | Method for preparing n- (bicyclo- hetero- cyclyl)- 4- piperidinamines | |
| ATE86110T1 (de) | Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten. | |
| YU29892A (sh) | Postupak za stereoselektivno dobijanje supstituisanih piperidina | |
| ATE121389T1 (de) | Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen. | |
| KR860004918A (ko) | 트리사이클로 화합물의 제조방법 | |
| MY101863A (en) | Carbocyclic or heterocyclic carboxylic acid esters and amides of a cyclic alkohol and its use in the treatment of psychiatric disorders | |
| AT386201B (de) | Verfahren zum herstellen neuer n-imidazolylderivate von bicyclischen verbindungen und ihren pharmazeutisch annehmbaren salzen | |
| BG94282A (bg) | 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они | |
| ES2078962T3 (es) | Nuevas 8-sustituidas-2-amino-tetralinas. | |
| UY23624A1 (es) | Procedimiento para la preparacion de nuevos derivados de indol | |
| ES2044981T3 (es) | Un proceso para la preparacion de nuevos derivados de 4(3h)-quinazolinona. | |
| DE69407407D1 (de) | Ampa antagonisten und behandlungsmethode | |
| ATE101147T1 (de) | Pharmazeutisch verwendbare polymorphe modifikation von buspiron. | |
| ES2058247T3 (es) | 4-hidroxicinnolin-carboxamidas, su utilizacion y metodo de preparacion. | |
| DE3852246D1 (de) | Ethyl-(+)-Apovincaminat zur Behandlung der Demyelinisierung klinischer Erscheinungen autoimmunen Ursprungs. | |
| DE3667789D1 (de) | Piperazin-1-yl-ergolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ES2056873T3 (es) | Derivados de 1-acil-2,3-dihidro-4-(1h)-quinolinona-4-oxima, procedimiento para producirlos y uso de los mismos. | |
| ATA154883A (de) | Verfahren zum herstellen neuer kondensierter cycloaliphatischer derivate von substituierten pyrido-(1,2-a)-pyrimidinen | |
| DK85083D0 (da) | Fremgangsmade til fremstilling af dodecahydrotriphenylen-, decahydro-1h-cyclopenta(1)phenanthren-, decahydro-1h-pyrido(1,2-f)phenanthridin- eller decahydropyrrolo(1,2-f)phenanthridin-forbindelser eller farmaceutisk acceptable salte deraf | |
| AT194849B (de) | Verfahren zur Herstellung von neuen 2-(Stilbyl-4")-(4,5-arylo)-1,2,3-triazolsulfonylverbindungen | |
| IT8322736A0 (it) | Processo per la preparazione di 2-alogeno ergoline per via elettrochimica. | |
| DE3664044D1 (de) | N,n-dialkylaminoalkyl-hexahydro-5-oxo-1h-pyrrolizine-3-carboxamides | |
| AT375368B (de) | Verfahren zur herstellung von als histamin h2rezeptor-antagonisten wirkenden 3-nitropyrrolderivaten | |
| BR9706491A (pt) | Compostos de elipticina processo para a sua preparação e composições farmacêuticas contendo os mesmos |